Related references
Note: Only part of the references are listed.An interactive web-based dashboard to track COVID-19 in real time
Ensheng Dong et al.
LANCET INFECTIOUS DISEASES (2020)
Soluble Urokinase Receptor and Acute Kidney Injury
Salim S. Hayek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
Safiya Richardson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology
Daniel Batlle et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia
Guangchang Pei et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Collapsing glomerulopathy in a COVID-19 patient
Sebastien Kissling et al.
KIDNEY INTERNATIONAL (2020)
Acute kidney injury in patients hospitalized with COVID-19
Jamie S. Hirsch et al.
KIDNEY INTERNATIONAL (2020)
Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China
Hua Su et al.
KIDNEY INTERNATIONAL (2020)
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study
Matthew J. Cummings et al.
LANCET (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Management of acute kidney injury in patients with COVID-19
Claudio Ronco et al.
LANCET RESPIRATORY MEDICINE (2020)
Multiorgan and Renal Tropism of SARS-CoV-2
Victor G. Puelles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Ensuring Sustainability of Continuous Kidney Replacement Therapy in the Face of Extraordinary Demand: Lessons From the COVID-19 Pandemic
Horng-Ruey Chua et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2020)
Collapsing Glomerulopathy in a Patient With COVID-19
Christopher P. Larsen et al.
KIDNEY INTERNATIONAL REPORTS (2020)
MO009NEUTRALIZATION OF UPAR WITH AN ANTI-UPAR ANTIBODY AMELIORATES RECURRENT FSGS SERA INDUCED PODOCYTE INJURY
Flavio Vincenti et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2020)
COVID-19-Related Glomerulopathy: A Report of 2 Cases of Collapsing Focal Segmental Glomerulosclerosis
Sandeep Magoon et al.
KIDNEY MEDICINE (2020)
Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia
Nikoletta Rovina et al.
CRITICAL CARE (2020)
Soluble Urokinase Receptor and Acute Kidney Injury
Ulf Schoenermarck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Analytical, biochemical and clearance considerations of soluble urokinase plasminogen activator receptor (suPAR) in healthy individuals
Janice Chew-Harris et al.
CLINICAL BIOCHEMISTRY (2019)
uPAR isoform 2 forms a dimer and induces severe kidney disease in mice
Changli Wei et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
The REDCap consortium: Building an international community of software platform partners
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2019)
Soluble Urokinase Plasminogen Activator Receptor and Decline in Kidney Function in Autosomal Dominant Polycystic Kidney Disease
Salim S. Hayek et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Inhibiting the urokinase-type plasminogen activator receptor system recovers STZ-induced diabetic nephropathy
Massimo Dal Monte et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Neutrophils are a main source of circulating suPAR predicting outcome in critical illness
Hendrik Gussen et al.
JOURNAL OF INTENSIVE CARE (2019)
C3a and suPAR drive versican V1 expression in tubular cells of focal segmental glomerulosclerosis
Runhong Han et al.
JCI INSIGHT (2019)
Prognostic value of suPAR and hs-CRP on cardiovascular disease
Marie Zoga Diederichsen et al.
ATHEROSCLEROSIS (2018)
Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine
S. D. Weisbord et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Motility of human renal cells is disturbed by infection with pathogenic hantaviruses
Stefan Haegele et al.
BMC INFECTIOUS DISEASES (2018)
Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans with CKD
Shengyuan Luo et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease
Eunsil Hahm et al.
NATURE MEDICINE (2017)
Elevated Soluble Urokinase Plasminogen Activator Receptor and Proenkephalin Serum Levels Predict the Development of Acute Kidney Injury after Cardiac Surgery
Jana C. Mossanen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
A tripartite complex of suPAR, APOL1 risk variants and αvβ3 integrin on podocytes mediates chronic kidney disease
Salim S. Hayek et al.
NATURE MEDICINE (2017)
Association of Serum Soluble Urokinase Receptor Levels With Progression of Kidney Disease in Children
Franz Schaefer et al.
JAMA PEDIATRICS (2017)
Kidney disease in Puumala hantavirus infection
Jukka Mustonen et al.
INFECTIOUS DISEASES (2017)
Cardiovascular Disease Biomarkers and suPAR in Predicting Decline in Renal Function: A Prospective Cohort Study
Salim S. Hayek et al.
KIDNEY INTERNATIONAL REPORTS (2017)
Inflammation in AKI: Current Understanding, Key Questions, and Knowledge Gaps
Hamid Rabb et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
suPAR: A New Biomarker for Cardiovascular Disease?
Gethin W. Hodges et al.
CANADIAN JOURNAL OF CARDIOLOGY (2015)
Soluble Urokinase Receptor and Chronic Kidney Disease
Salim S. Hayek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Soluble Urokinase Plasminogen Activator Receptor Level Is an Independent Predictor of the Presence and Severity of Coronary Artery Disease and of Future Adverse Events
Danny J. Eapen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score
Stig Lyngbaek et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Circulating suPAR in Two Cohorts of Primary FSGS
Changli Wei et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Inflammation in HIV-Infected Patients: Impact of HIV, Lifestyle, Body Composition, and Demography - A Cross Sectional Cohort Study
Anne Langkilde et al.
PLOS ONE (2012)
The Urokinase Receptor System, A Key Regulator at the Intersection between Inflammation, Immunity, and Coagulation
Mario Del Rosso et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Acute kidney injury in patients with influenza A (H1N1) 2009
Ville Pettilae et al.
INTENSIVE CARE MEDICINE (2011)
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
Changli Wei et al.
NATURE MEDICINE (2011)
Detection of suPAR in the Saliva of Healthy Young Adults: Comparison with Plasma Levels
Anna Gustafsson et al.
BIOMARKER INSIGHTS (2011)
Characteristics of Acute Kidney Injury in Patients Infected with the 2009 Influenza A (H1N1) Virus
Regina C. R. M. Abdulkader et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Regulation of cell signalling by uPAR
Harvey W. Smith et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
suPAR: The molecular crystal ball
Maria Thuno et al.
DISEASE MARKERS (2009)
Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2009)
Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy
Ove Andersen et al.
JOURNAL OF MEDICAL VIROLOGY (2008)
Modification of kidney barrier function by the urokinase receptor
Changli Wei et al.
NATURE MEDICINE (2008)
Structure of human urokinase plasminogen activator in complex with its receptor
Q Huai et al.
SCIENCE (2006)
Thoracic and abdominal aortic aneurysms
EM Isselbacher
CIRCULATION (2005)
The murine receptor for urokinase-type plasminogen activator is primarily expressed in tissues actively undergoing remodeling
H Solberg et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2001)
Share Paper
